NCT05971225 Verifying Remote Monitoring Effect on Net Cardiovascular Outcome; RemoteVerify (RêVe)
| NCT ID | NCT05971225 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Saint Vincent's Hospital, Korea |
| Condition | Congestive Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 450 participants |
| Start Date | 2023-11-11 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 450 participants in total. It began in 2023-11-11 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the impact and safety of wireless monitoring on the prognosis of heart failure patients with implanted pacemakers and defibrillators. It aims to examine the frequency of unplanned early hospital visits and the early diagnosis/intervention of disease exacerbation based on the presence or absence of wireless monitoring. Additionally, the study analyzes the influence of wireless monitoring on the patient's disease progression as well as satisfaction of the study participants.
Eligibility Criteria
Inclusion Criteria: * consented heart failure patients (LVEF\<=40%) with Biotronik wireless monitoring capable ICD/CRTs aged \>20 years * patients who are new to remote monitoring Exclusion Criteria: * For patients with a life expectancy of less than 6 months. If patient do not understand the contents of wireless monitoring or it is difficult to fill out the consent form due to cognitive decline. If wireless monitoring is performed with a patient enrolled in another clinical trial which remote monitoring may affect the previous enrolled study.
Frequently Asked Questions
Who can join the NCT05971225 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Congestive Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05971225 currently recruiting?
Yes, NCT05971225 is actively recruiting participants. Visit ClinicalTrials.gov or contact Saint Vincent's Hospital, Korea to inquire about joining.
Where is the NCT05971225 trial being conducted?
This trial is being conducted at Suwon, South Korea.
Who is sponsoring the NCT05971225 clinical trial?
NCT05971225 is sponsored by Saint Vincent's Hospital, Korea. The trial plans to enroll 450 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.